Pharmacological Characterization of a Fluorescent Uptake Assay for the Noradrenaline Transporter

Abstract

The noradrenaline transporter (NET) is a Na⁺/Cl^— dependent monoamine transporter that mediates rapid clearance of noradrenaline from the synaptic cleft, thereby terminating neuronal signaling. NET is an important target for drug development and is known to be modulated by many psychoactive compounds, including psychostimulants and antidepressants. Here, the authors describe the development and pharmacological characterization of a nonhomogeneous fluorescent NET uptake assay using the compound 4-(4-dimethylaminostyryl)-N-methylpyridinium (ASP⁺). Data presented show that the pharmacology of both the classic radiolabeled ³H-noradrenaline- and ASP⁺-based uptake assays are comparable, with an excellent correlation between potency obtained for known modulators of NET (r = 0.95, p < 0.0001). Furthermore, the fluorescent uptake assay is highly reproducible and has sufficiently large Z' values to be amenable for high-throughput screening (HTS). The advantage of this assay is compatibility with both 96- and 384-well formats and lack of radioactivity usage. Thus, the authors conclude that the assay is an inexpensive, viable approach for the identification and pharmacological profiling of small-molecule modulators of the monoamine transporter NET and may be amenable for HTS. (Journal of Biomolecular Screening 2007:378-384)

Keywords

biogenic monoamine noradrenaline norepinephrine transporter

References

Masson J. , Sagne C. , Hamon M. , El Mestikawy S. : Neurotransmitter transporters in the central nervous system . Pharmacol Rev 1999;51: 439-464 .

Gainetdinov RR , Caron MG : Monoamine transporters: from genes to behavior . Annu Rev Pharmacol Toxicol 2003;43: 261-284 .

Nelson N. : The family of Na+/Cl— neurotransmitter transporters . J Neurochem 1998;71: 1785-1803 .

Iversen L. : Neurotransmitter transporters: fruitful targets for CNS drug discovery . Mol Psychiatry 2000;5: 357-362 .

Tatsumi M. , Groshan K. , Blakely RD , Richelson E. : Pharmacological profile of antidepressants and related compounds at human monoamine transporters . Eur J Pharmacol 1997 ;340: 249-258 .

Aston-Jones G. , Rajkowski J. , Cohen J. : Role of locus coeruleus in attention and behavioral flexibility . Biol Psychiatry 1999 ;46: 1309-1320 .

Ressler KJ , Nemeroff CB : Role of norepinephrine in the pathophysiology and treatment of mood disorders . Biol Psychiatry 1999;46: 1219-1233 .

Southwick SM , Bremner JD , Rasmusson A. , Morgan CA III, Arnsten A. , Charney DS : Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder . Biol Psychiatry 1999;46: 1192-1204 .

Iversen L. : Neurotransmitter transporters and their impact on the development of psychopharmacology . Br J Pharmacol 2006;147(Suppl 1): S82-S88 .

10.

Lee CM , Javitch JA , Snyder SH : Characterization of [3H]desipramine binding associated with neuronal norepinephrine uptake sites in rat brain membranes . J Neurosci 1982;2: 1515-1525 .

11.

Pacholczyk T. , Blakely RD , Amara SG : Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter . Nature 1991 ;350: 350-354 .

12.

Reith ME , Wang LC , Dutta AK : Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity . J Neurosci Methods 2005;143: 87-94 .

13.

Allan L. , Leith JL , Papakosta M. , Morrow JA , Irving NG , McFerran BW , et al: Development of a novel high-throughput assay for the investigation of GlyT-1b neurotransmitter transporter function . Comb Chem High Throughput Screen 2006;9: 9-14 .

14.

Benjamin ER , Skelton J. , Hanway D. , Olanrewaju S. , Pruthi F. , IIyin IV , et al: Validation of a fluorescent imaging plate reader membrane potential assay for high-throughput screening of glycine transporter modulators . J Biomol Screen 2005 ;10: 365-373 .

15.

Hohage H. , Stachon A. , Feidt C. , Hirsch JR , Schlatter E. : Regulation of organic cation transport in IHKE-1 and LLC-PK1 cells: fluorometric studies with 4-(4-dimethylaminostyryl)-N-methylpyridinium . J Pharmacol Exp Ther 1998;286: 305-310 .

16.

Mason JN , Farmar H. , Tomlinson ID , Schwartz JW , Savchenko V. , DeFelice LJ , et al: Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation . J Neurosci Methods 2005; 143: 3-25 .

17.

Schwartz JW , Blakely RD , DeFelice LJ : Binding and transport in norepinephrine transporters: real-time, spatially resolved analysis in single cells using a fluorescent substrate . J Biol Chem 2003;278: 9768-9777 .

18.

Cheng Y. , Prusoff WH : Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction . Biochem Pharmacol 1973;22: 3099-3108 .

19.

Zhang JH , Chung TD , Oldenburg KR : A simple statistical parameter for use in evaluation and validation of high throughput screening assays . J Biomol Screen 1999;4: 67-73 .

20.

Rothman RB , Baumann MH , Dersch CM , Romero DV , Rice KC , Carroll FI , et al: Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin . Synapse 2001;39: 32-41 .

21.

Inazu M. , Takeda H. , Matsumiya T. : Functional expression of the norepinephrine transporter in cultured rat astrocytes . J Neurochem 2003;84: 136-144 .

22.

Paczkowski FA , Bryan-Lluka LJ , Porzgen P. , Bruss M. , Bonisch H. : Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters . J Pharmacol Exp Ther 1999;290: 761-767 .